What are Biosimilar Therapies and Why Should We Care?
Вставка
- Опубліковано 6 січ 2016
- Earn CME for related activities: www.naccme.com/gastro
Dedicated to the interests of the entire community of patients with inflammatory bowel disease (IBD), and designed to meet the educational needs of all healthcare professionals who treat and manage patients with IBD, 2015 Advances in Inflammatory Bowel Diseases: Crohn's & Colitis Foundation's Clinical and Research Conference is the foremost event for investigators and healthcare professionals to come together, share their knowledge and experience, and learn about the latest advances and new insights for personalized care of patients with IBD.
In this presentation, Dr. David T. Rubin discusses biosimilar therapies and why we should care about them.
© 2016 Imedex, LLC.
